Lowell General Hospital’s main and Saints campuses were recently recognized by both the American Heart Association and Massachusetts Department of Public Health for outstanding care of patients suffering a stroke, which is the fourth-leading cause of death in the Commonwealth and a leading cause of adult disability.
The Department of Public Health recognized the hospital with The Modified Rankin Scale greater than or equal to 85% Award from the Paul Coverdell National Acute Stroke Program, a Centers for Disease Control and Prevention (CDC) funded quality improvement collaborative that supports Primary Stroke Service hospitals. This award recognizes hospitals that complete the Modified Rankin Scale on at least 85% of stroke patients from January 2017 - December 2017. The Modified Rankin Scale is used to measure the degree of disability from the impact of a stroke on an individual’s daily activities from a range of 0-6. Immediate assessment and treatment is critical to help improve outcomes.
The AHA also awarded Lowell General Hospital the Target: StrokeSM Elite award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.
Lowell General Hospital earned the AHA honor by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients.